Evidence map›Paper›PMID 42249056›Full record

ArticleNPJ digital medicine2026

Age, emotional burden and deep brain stimulation electrode location shape Parkinson's disease quality of life.

Shiva Khoshnoud, Farzin Negahbani, Idil Cebi, Daniel Weiss, Alireza Gharabaghi

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shiva KhoshnoudInstitute for Neuromodulation and Neurotechnology, University Hospital Tübingen, Faculty of Medicine, University Tübingen, Tübingen, Germany.
Farzin NegahbaniInstitute for Neuromodulation and Neurotechnology, University Hospital Tübingen, Faculty of Medicine, University Tübingen, Tübingen, Germany.
Idil CebiInstitute for Neuromodulation and Neurotechnology, University Hospital Tübingen, Faculty of Medicine, University Tübingen, Tübingen, Germany.
Daniel WeissCenter for Neurology, Department for Neurodegenerative Diseases, and Hertie Institute for Clinical Brain Research, University Tübingen, Tübingen, Germany.
Alireza GharabaghiInstitute for Neuromodulation and Neurotechnology, University Hospital Tübingen, Faculty of Medicine, University Tübingen, Tübingen, Germany. alireza.gharabaghi@uni-tuebingen.de.

Funding

European Union's Joint Program for Neurodegenerative Disease Research (EU-JPND 2022-130) Recast (01ED2309)
6 · The paper itself

Abstract

Postoperative quality-of-life (QoL) outcomes after subthalamic deep brain stimulation in Parkinson's disease vary widely. Previous studies based on PDQ-39 summary scores have reported opposing relationships between baseline and postoperative QoL, reflecting analytic variability, measurement noise, and limited feature scope. To address these inconsistencies, we analyzed 130 patients using an explainable random-forest classifier with SHAP analysis trained to predict QoL changes exceeding minimal clinically important difference thresholds. Baseline variables included PDQ-39 subscores, along with demographic, motor, cognitive, and affective measures, and electrode coordinates derived from imaging. Predictors of QoL improvement included younger age, greater preoperative disease-related emotional burden, and electrode placement at the motor-associative transition in the right subthalamic nucleus. The model achieved an area under the curve of 0.70 on the held-out test set, with balanced sensitivity and specificity. Identifying interpretable cut-offs for age, emotional burden and electrode location supports individualized counseling and treatment planning, advancing outcome prediction in neuromodulation.

Identifiers

PMID42249056
PMCPMC13241528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.